Platelet pathogen reduction sets

The Medical Readiness Contracting Office - Pacific, supporting Tripler Army Medical Center in Hawaii, intends to procure Intercept platelet pathogen reduction sets from Cerus Corporation through a sole source award. These specialized medical devices will be used with government-owned Cerus Illuminator equipment for blood safety applications. The procurement is justified under FAR 13.501(a)(l)(ii), which permits non-competitive awards when only one responsible source can satisfy agency requirements, indicating that no other suppliers can provide compatible pathogen reduction sets for the existing equipment. While this is designated as a sole source procurement, the government will consider any capability statements or quotations received from other potential vendors. All inquiries must be submitted to lara.a.staley.civ@health.mil by August 11, 2025, just three days after the posting date.

This procurement does not utilize any set-aside designations and identifies Cerus Corporation as the intended sole source contractor due to equipment compatibility requirements. The contract structure includes a 12-month base period beginning October 1, 2025, followed by four additional 12-month option periods, creating a potential five-year contract extending through September 30, 2030. The procurement falls under NAICS code 325413 for In-Vitro Diagnostic Substance Manufacturing and PSC code 6550 for In Vitro Diagnostic Substances, Reagents, Test Kits and Sets. No specific award values or quantities are disclosed in this pre-solicitation notice. The government emphasizes that responses should not contain proprietary, classified, confidential, or sensitive information, and that submission of information does not obligate the government to award a contract or provide feedback to respondents.